Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| MoonLake Immunotherapeutics | MLTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 43.25 | 04:09:55 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 43.25 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 19.80 - 64.98 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 43.25 | USD |
MoonLake Immunotherapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.76B | 63.89M | - | 0 | -44.08M | -0.69 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
MoonLake Immunotherapeut... News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MLTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 43.71 | 43.88 | 40.68 | 42.54 | 375,686 | -0.46 | -1.05% |
| 1 Month | 50.08 | 52.92 | 40.68 | 46.03 | 424,678 | -6.83 | -13.64% |
| 3 Months | 56.03 | 64.98 | 40.68 | 50.44 | 495,666 | -12.78 | -22.81% |
| 6 Months | 53.16 | 64.98 | 35.11 | 49.27 | 572,205 | -9.91 | -18.64% |
| 1 Year | 22.57 | 64.98 | 19.80 | 48.23 | 602,783 | 20.68 | 91.63% |
| 3 Years | 12.37 | 64.98 | 4.25 | 41.96 | 357,666 | 30.88 | 249.64% |
| 5 Years | 12.37 | 64.98 | 4.25 | 41.96 | 357,666 | 30.88 | 249.64% |
MoonLake Immunotherapeut... Description
| MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. |
